Live News EQUITY FLASH L impact Nov 04, 2026, 12:58 PM UTC Pentixapharm Advances Preparations for Phase 3 PANDA Study Pentixapharm Holding AG reported progress in preparations for its Phase 3 PANDA study. SquawkNews Desk